Adam is responsible for the research of current and next-generation probiotics as well as building a strong portfolio of scientific data to support the commercial probiotic business. Adam focuses on the role of bacteria throughout life and the impact they have on our health. He studies the interactions between bacteria and the host microbiome at a molecular and clinically functional level. Prior to Chr. Hansen, Adam worked as the VP of Diagnostic Product Develop at Exiqon A/S in Denmark for 5 years and the Head of New Technologies in deCODE Genetics in Iceland.